Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival

BACKGROUND: The long term outcome (more than 15 years) of adjuvant treatment in patients with primary operable breast cancer has rarely been examined. METHODS: A randomised clinical trial of radiotherapy, chemotherapy (28 day cycles of cyclophosphamide, methotrexate and 5-fluorouracil) or both on wo...

Descripción completa

Detalles Bibliográficos
Autores principales: McArdle, Colin S, McMillan, Donald C, Greenlaw, Nicola, Morrison, David S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918580/
https://www.ncbi.nlm.nih.gov/pubmed/20673353
http://dx.doi.org/10.1186/1471-2407-10-398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918580/
https://www.ncbi.nlm.nih.gov/pubmed/20673353
http://dx.doi.org/10.1186/1471-2407-10-398

Ejemplares similares